2025 · 4th Quarter (Oct 1 - Dec 31)

AMERICAN UROLOGICAL ASSOCIATION

Filed by VENABLE LLP.

Open official filing

Source-reported fields

Filing overview

Type: 4th Quarter - Termination
Posted: Jan 9, 2026
Income: $30,000.00
Expenses: Not reported
Registrant: VENABLE LLP
Client: AMERICAN UROLOGICAL ASSOCIATION
Filing UUID: 38266a2f-6aa7-410a-84d6-0102efc09f13
Termination date: Dec 31, 2025

Literal source text

Lobbying issues and bill citations

BUD · Budget/Appropriations

FY 2026 Defense Appropriations funding for Bladder Cancer and Kidney Cancer; FY 2026 Labor Health & Human Services and Education Funding for National Institute of Health; Drug shortages

HCR · Health Issues

Specialty Physicians Advancing Rural Care Act (H.R. 4681 / S. 1380); PSA screening for HIM Act (H.R. 1300 / S. 297); Medicare physician payment issues; Telehealth policy issues; Price authorization issues; Medicine Patient Access & Practice Stabilization Act (H.R. 879); Public questions for the record on Senate U.S. Department of Health and Human Services confirmation hearings.

Literal federal measure citations: H.R. 4681, S. 1380, H.R. 1300, S. 297, H.R. 879

Relationship and amount limits

Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.